| Acute graft-versus-host disease—biologic process, prevention, and therapy R Zeiser, BR Blazar New England Journal of Medicine 377 (22), 2167-2179, 2017 | 1231 | 2017 |
| Origin, fate and dynamics of macrophages at central nervous system interfaces T Goldmann, P Wieghofer, MJC Jordão, F Prutek, N Hagemeyer, ... Nature immunology 17 (7), 797-805, 2016 | 1133 | 2016 |
| International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 796 | 2016 |
| Pathophysiology of chronic graft-versus-host disease and therapeutic targets R Zeiser, BR Blazar New England Journal of Medicine 377 (26), 2565-2579, 2017 | 696 | 2017 |
| Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease R Zeiser, N von Bubnoff, J Butler, M Mohty, D Niederwieser, R Or, J Szer, ... New England Journal of Medicine 382 (19), 1800-1810, 2020 | 663 | 2020 |
| Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068, 2015 | 629 | 2015 |
| Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production R Zeiser, VH Nguyen, A Beilhack, M Buess, S Schulz, J Baker, CH Contag, ... Blood 108 (1), 390-399, 2006 | 580 | 2006 |
| Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European … O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ... The Lancet Haematology 7 (2), e157-e167, 2020 | 520 | 2020 |
| Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R K Wilhelm, J Ganesan, T Müller, C Dürr, M Grimm, A Beilhack, CD Krempl, ... Nature medicine 16 (12), 1434-1438, 2010 | 511 | 2010 |
| Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation … A Burchert, G Bug, LV Fritz, J Finke, M Stelljes, C Röllig, E Wollmer, ... Journal of Clinical Oncology 38 (26), 2993-3002, 2020 | 487 | 2020 |
| Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells R Zeiser, DB Leveson-Gower, EA Zambricki, N Kambham, A Beilhack, ... Blood, The Journal of the American Society of Hematology 111 (1), 453-462, 2008 | 449 | 2008 |
| Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease S Spoerl, NR Mathew, M Bscheider, A Schmitt-Graeff, S Chen, T Mueller, ... Blood, The Journal of the American Society of Hematology 123 (24), 3832-3842, 2014 | 447 | 2014 |
| Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment G Mikhaylov, U Mikac, AA Magaeva, VI Itin, EP Naiden, I Psakhye, ... Nature nanotechnology 6 (9), 594-602, 2011 | 441 | 2011 |
| Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease R Zeiser, N Polverelli, R Ram, SK Hashmi, R Chakraverty, JM Middeke, ... New England Journal of Medicine 385 (3), 228-238, 2021 | 403 | 2021 |
| CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation K Rakhra, P Bachireddy, T Zabuawala, R Zeiser, L Xu, A Kopelman, ... Cancer cell 18 (5), 485-498, 2010 | 393 | 2010 |
| Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation C Toffalori, L Zito, V Gambacorta, M Riba, G Oliveira, G Bucci, M Barcella, ... Nature medicine 25 (4), 603-611, 2019 | 380 | 2019 |
| Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma T Flecken, N Schmidt, S Hild, E Gostick, O Drognitz, R Zeiser, ... Hepatology 59 (4), 1415-1426, 2014 | 375 | 2014 |
| Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion AM Paczulla, K Rothfelder, S Raffel, M Konantz, J Steinbacher, H Wang, ... Nature 572 (7768), 254-259, 2019 | 342 | 2019 |
| Continuous T cell receptor signals maintain a functional regulatory T cell pool JC Vahl, C Drees, K Heger, S Heink, JC Fischer, J Nedjic, N Ohkura, ... Immunity 41 (5), 722-736, 2014 | 342 | 2014 |
| Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage L Schwab, L Goroncy, S Palaniyandi, S Gautam, A Triantafyllopoulou, ... Nature medicine 20 (6), 648-654, 2014 | 327 | 2014 |
